The British Medicines and Healthcare Products Regulatory Agency announced that it had detected a total of 30 cases of blood clots in people who received the “AstraZeneca” Corona virus vaccine.
The agency added that among the cases it monitored, 25 new cases, and that no such cases were recorded after the use of the “Pfizer” vaccine.
The agency confirmed that it still believes that the benefits of the “AstraZeneca” vaccine outweigh the potential risk of blood clots.
The British agency had announced the monitoring of 5 such cases on March 18th, out of 11 million injections of the vaccine.
It is noteworthy that a number of countries, most of which are members of the European Union, have suspended the use of the “AstraZeneca” vaccine due to reports about blood clots in people who have received the vaccine, but the European Medicines Agency, after conducting additional studies, has not detected any direct link between these cases and the vaccine.
In general, its use resumed in most countries, while certain countries maintained some restrictions on the use of the “AstraZeneca” vaccine.